Today: 12 June 2026
Browse Category

NASDAQ:FULC 8 December 2025

Biggest Stock Gainers Today: Biotech Breakouts and IBM–Confluent Deal Lead U.S. Market Movers (December 8, 2025)

Biggest Stock Gainers Today: Biotech Breakouts and IBM–Confluent Deal Lead U.S. Market Movers (December 8, 2025)

U.S. stocks were little changed Monday ahead of the Federal Reserve meeting, with the S&P 500 and Dow down 0.03% and the Nasdaq 100 up 0.07%. Small-cap stocks surged, led by biotech firms on clinical trial results and M&A news. Cemtrex soared 134%, Structure Therapeutics 97%, and Wave Life Sciences 92%. The Russell 2000 rose 0.55% intraday.
8 December 2025
········

Stock Market Today

  • Bitcoin Hits $59,000 Bottom, Signaling End of Crypto Winter, Says Standard Chartered Analyst
    June 12, 2026, 3:19 PM EDT. Bitcoin has bottomed at around $59,000, marking a 53% decline from its October high and signaling the end of the crypto winter, Standard Chartered analyst Geoffrey Kendrick said. Data from CoinDesk confirms bitcoin hit $59,375 on June 5. Kendrick forecasts bitcoin reaching $100,000 and ether $4,000 by year-end. Key factors include significant bitcoin ETF selling, with over $5.72 billion redeemed since early May, alongside ETF investors reallocating funds to Elon Musk's SpaceX IPO, which debuted on Nasdaq about 26% above its $150 initial price.

Latest articles

FreeCast Rallies on DIRECTV Deal, But Risks Remain for CAST

FreeCast Rallies on DIRECTV Deal, But Risks Remain for CAST

12 June 2026
FreeCast (NASDAQ: CAST) soared 147% to $1.59 on nearly 148 million shares after expanding its DIRECTV partnership to residential and Platform-as-a-Service channels, but the surge came amid extreme volatility, ongoing heavy losses, just $119,302 in cash, and a going-concern warning, with no new financial terms or subscriber targets disclosed.
Cuprina jumps after Nasdaq compliance update, but risks remain

Cuprina jumps after Nasdaq compliance update, but risks remain

12 June 2026
CUPR soared 74% to $4.20 after Cuprina said Nasdaq confirmed it had regained compliance with minimum bid price rules, removing immediate delisting risk following a 1-for-8 share consolidation; Friday’s rally reflects relief over trading continuity, but with 2025 revenue at just US$38,789 and net loss at US$3.63 million, investors now await proof of commercial traction in chronic wound care markets.
Go toTop